rxstat › Shortages › Escitalopram
Escitalopram shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Escitalopram products are in shortage in Canada (4 of 41 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 20, 2026.
In shortage since
Sep 9, 2025
Est. full return
Jul 20, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageACH-ESCITALOPRAM
20MG · TABLET · ACCORD HEALTHCARE INC
DIN 02434660 · since ?, est. end Jul 17, 2026 · Demand increase for the drug.
Active shortageACH-ESCITALOPRAM
10MG · TABLET · ACCORD HEALTHCARE INC
DIN 02434652 · since ?, est. end Jul 17, 2026 · Demand increase for the drug.
Active shortageTEVA-ESCITALOPRAM
20MG · TABLET · TEVA CANADA LIMITED
DIN 02318202 · since Jun 17, 2026, est. end Jul 20, 2026 · Disruption of the manufacture of the drug.
Active shortageESCITALOPRAM
20MG · TABLET · SANIS HEALTH INC
DIN 02430126 · since Sep 9, 2025, no end estimate · Disruption of the manufacture of the drug.
AnticipatedTEVA-ESCITALOPRAM
10MG · TABLET · TEVA CANADA LIMITED
DIN 02318180 · Disruption of the manufacture of the drug.
AnticipatedESCITALOPRAM
10MG · TABLET · SANIS HEALTH INC
DIN 02430118 · Disruption of the manufacture of the drug.
ResolvedTEVA-ESCITALOPRAM
20MG · TABLET · TEVA CANADA LIMITED
DIN 02318202 · ended Jun 9, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-ESCITALOPRAM
20MG · TABLET · TEVA CANADA LIMITED
DIN 02318202 · ended Jun 10, 2026 · Disruption of the manufacture of the drug.
DiscontinuedPMS-ESCITALOPRAM
20MG · TABLET · PHARMASCIENCE INC
DIN 02469251
ResolvedPMS-ESCITALOPRAM
20MG · TABLET · PHARMASCIENCE INC
DIN 02469251 · ended May 4, 2026 · Disruption of the manufacture of the drug.
ResolvedPMS-ESCITALOPRAM
20MG · TABLET · PHARMASCIENCE INC
DIN 02469251 · ended May 4, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-ESCITALOPRAM
20MG · TABLET · TEVA CANADA LIMITED
DIN 02318202 · ended Mar 25, 2026 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Escitalopram is currently affected by 4 active shortage reports filed with Health Canada by ACCORD HEALTHCARE INC, TEVA CANADA LIMITED, SANIS HEALTH INC.
The reported causes are: demand increase for the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Escitalopram is classified under “ANTIDEPRESSANTS” (ATC N06AB).
Recent changes
Common questions
When will Escitalopram be back in stock in Canada?
The latest manufacturer estimate is Jul 20, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Escitalopram in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.